BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34733232)

  • 1. The Genetic Basis of Phenotypic Heterogeneity in the Neuronal Ceroid Lipofuscinoses.
    Gardner E; Mole SE
    Front Neurol; 2021; 12():754045. PubMed ID: 34733232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of the neuronal ceroid lipofuscinoses (Batten disease).
    Mole SE; Cotman SL
    Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2237-41. PubMed ID: 26026925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.
    Warrier V; Vieira M; Mole SE
    Biochim Biophys Acta; 2013 Nov; 1832(11):1827-30. PubMed ID: 23542453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease).
    Kim WD; Wilson-Smillie MLDM; Thanabalasingam A; Lefrancois S; Cotman SL; Huber RJ
    Front Cell Dev Biol; 2022; 10():812728. PubMed ID: 35252181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.
    Kaminiów K; Kozak S; Paprocka J
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses.
    Butz ES; Chandrachud U; Mole SE; Cotman SL
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165571. PubMed ID: 31678159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic perspectives in the neuronal ceroid lipofuscinoses.
    Kmoch S; Stránecký V; Emes RD; Mitchison HM
    Biochim Biophys Acta; 2013 Nov; 1832(11):1831-41. PubMed ID: 23274885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell biology and function of neuronal ceroid lipofuscinosis-related proteins.
    Kollmann K; Uusi-Rauva K; Scifo E; Tyynelä J; Jalanko A; Braulke T
    Biochim Biophys Acta; 2013 Nov; 1832(11):1866-81. PubMed ID: 23402926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses.
    Mukherjee AB; Appu AP; Sadhukhan T; Casey S; Mondal A; Zhang Z; Bagh MB
    Mol Neurodegener; 2019 Jan; 14(1):4. PubMed ID: 30651094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.
    Villani NA; Bullock G; Michaels JR; Yamato O; O'Brien DP; Mhlanga-Mutangadura T; Johnson GS; Katz ML
    Mol Genet Metab; 2019 May; 127(1):107-115. PubMed ID: 31101435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal ceroid lipofuscinosis associated with an MFSD8 mutation in Chihuahuas.
    Ashwini A; D'Angelo A; Yamato O; Giordano C; Cagnotti G; Harcourt-Brown T; Mhlanga-Mutangadura T; Guo J; Johnson GS; Katz ML
    Mol Genet Metab; 2016 Aug; 118(4):326-32. PubMed ID: 27211611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent insights into the networking of CLN genes and proteins in mammalian cells.
    Huber RJ
    J Neurochem; 2023 Jun; 165(5):643-659. PubMed ID: 37022340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).
    Hawkins-Salsbury JA; Cooper JD; Sands MS
    Biochim Biophys Acta; 2013 Nov; 1832(11):1906-9. PubMed ID: 23747979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.
    Basak I; Wicky HE; McDonald KO; Xu JB; Palmer JE; Best HL; Lefrancois S; Lee SY; Schoderboeck L; Hughes SM
    Cell Mol Life Sci; 2021 May; 78(10):4735-4763. PubMed ID: 33792748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal ceroid lipofuscinoses.
    Jalanko A; Braulke T
    Biochim Biophys Acta; 2009 Apr; 1793(4):697-709. PubMed ID: 19084560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics of the neuronal ceroid lipofuscinoses.
    Mole S; Gardiner M
    Epilepsia; 1999; 40 Suppl 3():29-32. PubMed ID: 10446748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NCL diseases - clinical perspectives.
    Schulz A; Kohlschütter A; Mink J; Simonati A; Williams R
    Biochim Biophys Acta; 2013 Nov; 1832(11):1801-6. PubMed ID: 23602993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestry.
    Guo J; Johnson GS; Brown HA; Provencher ML; da Costa RC; Mhlanga-Mutangadura T; Taylor JF; Schnabel RD; O'Brien DP; Katz ML
    Mol Genet Metab; 2014 Aug; 112(4):302-9. PubMed ID: 24953404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
    Mole SE; Mitchison HM; Munroe PB
    Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.